Novavax Shot Approved as Fifth COVID Vaccine
The European Union has approved the use of Novavax’s COVID-19 vaccine in people 18
Novavax to be EU’s fifth approved COVID vaccine
The European Union’s drugs regulator will determine on Monday the possibility of authorizing Novavax’s
Novavax and EC seal 200 million COVID-19 vaccine
Today, Novavax, Inc. announced that it had signed a contract with the European Commission
